Dave Weiner

Stock Analyst at Piper Sandler

(1.54)

# 3,743

Out of 5,182 analysts

9

Total ratings

50%

Success rate

1.49%

Average return

Main Sectors:

Healthcare Consumer Discretionary

Top Industries:

Diagnostics & Research Apparel Retail

Stocks Rated by Dave Weiner

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	MYGN Myriad Genetics	Maintains: Overweight	$9 → $8.5	$5.08	+67.32%	4	Nov 11, 2025
	LULU lululemon athletica inc.	Upgrades: Buy	n/a	$167.28	-	5	Dec 14, 2017

Myriad Genetics

Nov 11, 2025

Maintains: Overweight

Price Target: $9 → $8.5

Current: $5.08

Upside: +67.32%

lululemon athletica inc.

Dec 14, 2017

Upgrades: Buy

Price Target: n/a

Current: $167.28

Upside: -